A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery
Public ClinicalTrials.gov record NCT01777165. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind,Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety and efficacy of ABT-719 in preventing acute kidney injury in patients undergoing high risk cardiac surgery.
Study identification
- NCT ID
- NCT01777165
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2013 (Type not available)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- Jul 7, 2021
2013 – 2014
United States locations
- U.S. sites
- 38
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 83739 | Danbury | Connecticut | 06810 | — |
| Site Reference ID/Investigator# 87720 | Gainesville | Florida | 32610 | — |
| Site Reference ID/Investigator# 83746 | Jacksonville | Florida | 32207 | — |
| Site Reference ID/Investigator# 83733 | Jacksonville | Florida | 32216 | — |
| Site Reference ID/Investigator# 89178 | Tampa | Florida | 33613 | — |
| Site Reference ID/Investigator# 87693 | Atlanta | Georgia | 30322 | — |
| Site Reference ID/Investigator# 87717 | Augusta | Georgia | 30912 | — |
| Site Reference ID/Investigator# 89180 | Fort Wayne | Indiana | 46804 | — |
| Site Reference ID/Investigator# 101942 | Indianapolis | Indiana | 46237 | — |
| Site Reference ID/Investigator# 85917 | Lexington | Kentucky | 40536 | — |
| Site Reference ID/Investigator# 83732 | Bethesda | Maryland | 20814 | — |
| Site Reference ID/Investigator# 83724 | Boston | Massachusetts | 02115 | — |
| Site Reference ID/Investigator# 83745 | Boston | Massachusetts | 02135 | — |
| Site Reference ID/Investigator# 83750 | Grand Blanc | Michigan | 48439 | — |
| Site Reference ID/Investigator# 83747 | Petoskey | Michigan | 49770 | — |
| Site Reference ID/Investigator# 83744 | Royal Oak | Michigan | 48073 | — |
| Site Reference ID/Investigator# 85913 | Saint Paul | Minnesota | 55102 | — |
| Site Reference ID/Investigator# 96455 | St Louis | Missouri | 63131 | — |
| Site Reference ID/Investigator# 91253 | Omaha | Nebraska | 68198-2315 | — |
| Site Reference ID/Investigator# 93673 | Newark | New Jersey | 07102 | — |
| Site Reference ID/Investigator# 83722 | New York | New York | 10032 | — |
| Site Reference ID/Investigator# 89176 | Asheville | North Carolina | 28803 | — |
| Site Reference ID/Investigator# 83723 | Durham | North Carolina | 27710 | — |
| Site Reference ID/Investigator# 92413 | Gastonia | North Carolina | 28054 | — |
| Site Reference ID/Investigator# 87733 | Winston-Salem | North Carolina | 27103 | — |
| Site Reference ID/Investigator# 83735 | Cincinnati | Ohio | 45219 | — |
| Site Reference ID/Investigator# 91813 | Columbus | Ohio | 43210 | — |
| Site Reference ID/Investigator# 83738 | Toledo | Ohio | 43606 | — |
| Site Reference ID/Investigator# 91693 | Portland | Oregon | 97225 | — |
| Site Reference ID/Investigator# 89182 | Springfield | Oregon | 97447 | — |
| Site Reference ID/Investigator# 83734 | Pittsburgh | Pennsylvania | 15232 | — |
| Site Reference ID/Investigator# 83730 | Knoxville | Tennessee | 37923 | — |
| Site Reference ID/Investigator# 101876 | Memphis | Tennessee | 38120 | — |
| Site Reference ID/Investigator# 90614 | Charlottesville | Virginia | 22908 | — |
| Site Reference ID/Investigator# 83725 | Richmond | Virginia | 23225 | — |
| Site Reference ID/Investigator# 87714 | Tacoma | Washington | 98405 | — |
| Site Reference ID/Investigator# 91814 | Madison | Wisconsin | 53792 | — |
| Site Reference ID/Investigator# 87739 | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01777165, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2021 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01777165 live on ClinicalTrials.gov.